Bladder Cancer: ASCO Tumor Boards

This is a case-based activity that includes discussion of a 60-year-old male smoker with hypertension, hyperlipidemia, and obesity who presents to his primary care physician with three days of painless gross hematuria. He has no known drug allergies and current medications include aspirin, hydrochlorothiazide, and atorvastatin. He has no known family history of cancer and consumes 1 drink per day. Physical examination is normal/unremarkable. Work up includes referral to urology for cystoscopy, hematuria-protocol CT to evaluate bladder mass, nodes, and upper tracts as well as urine cytology.

Learning Objectives

  • Describe the primary treatment options for localized, muscle-invasive bladder cancer
  • Explain the selection criteria for successful bladder preservation as an alternative to radical cystectomy
  • Discuss the impact of treatment on patient quality of life
  • Collaborate across different specialties and with all members of the oncology care team to provide effective and patient-centered treatment and supportive care

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits
  • ABIM MOC Points
  • CNE Contact Hours
  • CPE Credits
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.

Important Notes

  • This course expires on February 23, 2020. Participants must complete all necessary course components by this date to receive credit.
  • This course is available as part of the 2017 ASCO Tumor Boards bundle.